I also had a great email exchange with Dr Seymour las week!
Here is a part of that email:
The problem is that the biotech sector is getting hammered at the moment
As we move towards our human trials, remember that we have $38M in the bank
If trials work out as we hope they will, the stock price will certainly reflect that fact!
Remember we were down to 30 cents (pre-split) not too long ago..
And we were up to $7.60 not long ago also
Our stock is and always has been volatile
Otherwise, everything is going well
Look at what we're doing
I'm here in Europe to finish the H7N9, H5N1 and MERS contracts with both European groups. We're working with Eva Harris on Dengue, and finishing our herpes work at the medical school in Ohio! As soon as the genital herpes work us completed, we will do our confirmatory ophthalmic herpes studies.
The plant is almost done and the scale-up is well underway in the current labs
Preliminary tox studies showed absolutely no evidence of toxicity and we're preparing product for the large-scale tox studies at BASI.
I couldn't be more excited about our prospects,